结局变量,N,治疗效应系数,标准误,95%CI下限,95%CI上限,P值,R²,显著,控制变量,解释
ALT变化,171,-1.0483979088259974,1.7078614458954828,-4.420477477467304,2.3236816598153087,0.5401493488521515,0.045636770534412174,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组ALT变化无显著减少1.05单位
AST变化,171,0.631196826476449,1.408191064750116,-2.149199867646074,3.4115935205989723,0.6545735185569662,0.028564476762478752,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组AST变化无显著增加0.63单位
肝硬度变化,126,-0.8175628910897623,0.5369266196006764,-1.8806402305193477,0.24551444833982305,0.13047181912997094,0.4374467867552516,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组肝硬度变化无显著减少0.82单位
